Review
Published on 20 Apr 2022
The Landscape of Immunotherapy Resistance in NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.817548
- 15,843 views
- 40 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,601 articles
Articles
Original Research
Published on 14 Apr 2022
Prognostic Implication of Energy Metabolism-Related Gene Signatures in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.867470
- 5,347 views
- 6 citations
Review
Published on 14 Apr 2022
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.840783
- 8,786 views
- 22 citations
Review
Published on 12 Apr 2022
Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.787080
- 5,733 views
- 5 citations
Original Research
Published on 12 Apr 2022
Airway Microbiota in Patients With Synchronous Multiple Primary Lung Cancer: The Bacterial Topography of the Respiratory Tract
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.811279
- 2,389 views
- 3 citations
Review
Published on 08 Apr 2022
Thymic Carcinoma: A Review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.808019
- 12,526 views
- 4 citations
Review
Published on 07 Apr 2022
Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.853501
- 8,336 views
- 4 citations
Review
Published on 06 Apr 2022
Targeting ALK Rearrangements in NSCLC: Current State of the Art
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.863461
- 17,348 views
- 39 citations
Review
Published on 01 Apr 2022
Molecular Mechanisms Involving the Sonic Hedgehog Pathway in Lung Cancer Therapy: Recent Advances
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.729088
- 3,893 views
- 12 citations
Original Research
Published on 31 Mar 2022
A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.835582
- 3,167 views
- 11 citations
Review
Published on 31 Mar 2022
BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.863043
- 25,037 views
- 39 citations
Case Report
Published on 31 Mar 2022
Effective Systemic Treatment of Choroidal Metastases NSCLC With Surgery After Crizotinib: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.789941
- 1,686 views
Review
Published on 29 Mar 2022
HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.860313
- 18,291 views
- 22 citations
Case Report
Published on 29 Mar 2022
Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case Series
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.872225
- 3,047 views
- 4 citations
Original Research
Published on 28 Mar 2022
Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.844691
- 3,171 views
- 3 citations
Original Research
Published on 28 Mar 2022
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.856132
- 4,183 views
- 3 citations